These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37096780)

  • 1. Generation of Rh D-negative blood using CRISPR/Cas9.
    Xu L; Zeng Q; Liang L; Yang Z; Qu M; Li H; Zhang B; Zhang J; Yuan X; Chen L; Fan Z; He L; Nan X; Yue W; Xie X; Pei X
    Cell Prolif; 2023 Nov; 56(11):e13486. PubMed ID: 37096780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells.
    Pandey P; Zhang N; Curtis BR; Newman PJ; Denomme GA
    J Cell Mol Med; 2021 Oct; 25(19):9340-9349. PubMed ID: 34547166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs.
    Ludwik KA; Telugu N; Schommer S; Stachelscheid H; Diecke S
    STAR Protoc; 2023 Sep; 4(3):102406. PubMed ID: 37481731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
    Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
    Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rh D blood group conversion using transcription activator-like effector nucleases.
    Kim YH; Kim HO; Baek EJ; Kurita R; Cha HJ; Nakamura Y; Kim H
    Nat Commun; 2015 Jun; 6():7451. PubMed ID: 26078220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
    Higo S; Hikoso S; Miyagawa S; Sakata Y
    Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
    Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
    Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
    Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
    Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
    Jurlina SL; Jones MK; Agarwal D; De La Toba DV; Kambli N; Su F; Martin HM; Anderson R; Wong RM; Seid J; Attaluri SV; Chow M; Wahlin KJ
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.
    Umbach A; Maule G; Kheir E; Cutarelli A; Foglia M; Guarrera L; Fava LL; Conti L; Garattini E; Terao M; Cereseto A
    Stem Cell Res Ther; 2022 Sep; 13(1):440. PubMed ID: 36056433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
    Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
    Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs.
    Zhang JP; Yang ZX; Zhang F; Fu YW; Dai XY; Wen W; Zhang B; Choi H; Chen W; Brown M; Baylink D; Zhang L; Qiu H; Wang C; Cheng T; Zhang XB
    Sci China Life Sci; 2021 Sep; 64(9):1449-1462. PubMed ID: 33420926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing.
    Paulsen BS; Mandal PK; Frock RL; Boyraz B; Yadav R; Upadhyayula S; Gutierrez-Martinez P; Ebina W; Fasth A; Kirchhausen T; Talkowski ME; Agarwal S; Alt FW; Rossi DJ
    Nat Biomed Eng; 2017 Nov; 1(11):878-888. PubMed ID: 31015609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.